Biodefense Market Report (2021-2031) | The Insight Partners
The biodefense market size in 2021 stood at US$ 12.37 billion and is projected to reach US$ 21.62 billion by 2031. The market is expected to register a CAGR of 6.1% in 2023–2031. Big data and artificial intelligence techniques offer huge possibilities for performing technical assessments of the risk and possibility of different biothreats and an unparalleled opportunity for mapping disease outbreaks. Thus, predictive analytics can help to reshape the biodefense industry, serving as a key biodefense market trends.
Biodefense Market Analysis
The lethal and naturally occurring viruses can now be easily modified to cause even more harm due to recent scientific advancements in the field of genetic engineering and biotechnology. Growing recognition of the potentially disastrous effects of biological attacks and outbreaks has increased the demand for biodefense solutions. Worldwide, governments are making significant investments in biodefense capabilities, which are supporting the market's expansion. Technological developments and a growing emphasis on research and development have also resulted in the launch of sophisticated and innovative biodefense solutions. The evolution of biodefense solutions is propelled by technological innovations such as synthetic biology, genomics, and data analytics, which provide improved capacities for identifying, characterizing, and mitigating biological threats. In addition, partnerships between governmental, defense, and commercial organizations have supported the development of comprehensive biodefense strategies and boosted market expansion.
Biodefense Market Overview
Biodefense refers to the range of activities and technologies that aim to restore the biosecurity of a country that is or may be, subject to biological threats or infectious diseases. It helps counter the potential risks associated with pandemics, bioterrorism, and other biological emergencies. The federal government in the US coordinates programs and sets up budgets to prevent, respond, and take action against biological disasters. The US biological defense program, also known as the National Biodefense Strategy, entails collective efforts by numerous levels of the government in association with private bodies and other stakeholders for the conduction of biodefense activities. In addition, the National Collaborating Centre for Infectious Diseases is an organization in Canada that aims to provide recent information on emerging infectious diseases to policymakers, public health practitioners, health inspectors, and others through webinars, podcasts, online resources, and publications. Thus, the efforts and initiatives undertaken by the government to strengthen the biodefense system are likely to support the market growth during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biodefense Market: Strategic Insights
Market Size Value in US$ 4,108.24 Million in 2019 Market Size Value by US$ 8,350.74 Million by 2027 Growth rate CAGR of 9.4% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biodefense Market: Strategic Insights
| Market Size Value in | US$ 4,108.24 Million in 2019 |
| Market Size Value by | US$ 8,350.74 Million by 2027 |
| Growth rate | CAGR of 9.4% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Biodefense Market Drivers and Opportunities
Presence of Favourable Government Initiatives to Drive the Market Growth
Governments in developed nations take a variety of actions and adopt preventative steps to withstand bioterrorism attacks. The government constantly maintains supplies of vaccines and bio-threat-detecting tools to protect the public. This is attributed to rising federal financing, technical breakthroughs, and growing public awareness. The presence of major players is also encouraging for the market. In 2018, the US government released the National Biodefense Strategy and Implementation Plan, the National Security Strategy, the National Defense Strategy, and the National Counterterrorism Strategy, and the National Counter WMD Strategy, all of which include biosecurity and biodefense.
Moreover, in emerging markets such as India, several facilities, such as the Defense Research and Development Organization, are developing defensive measures to combat biological attacks. Significant efforts are being made to prepare the military force for a biological attack. In the past two decades, there has been a continuing increase in the focus on spreading awareness about bioterrorism across all nations, along with various proposals and meetings to fight such threats, which is one of the major reasons driving the demand for biodefense. The initiatives of governments globally open a window of chance for companies involved in the biodefense sector, thereby driving market growth.
Enhanced Adoption of Technologies to Favor Market Growth
Increased adoption of technologies, such as gene chips for pathogen detection in forensic division, database management systems, advanced detector hardware in biodefense-related drug development, and nanotechnology, is being successfully used to strengthen biological defense techniques. Most of these technologies are employed either independently or jointly to design and develop various biodefense tools. The technology that is currently the most significant to biodefense is closely related to genetic engineering, a technology based on the artificial manipulation and transfer of genetic material. At the same time, gene therapy could be effectively used to cure various diseases. Many predict that future bioweapons could be designer bioweapons, and this technology could play a very important role in finding cures for many diseases unknown at present. Recent advances in molecular biology and genetic engineering have led to new vaccine development strategies and are likely to create considerable growth opportunities for the biodefense market in the future.
Biodefense Market Report Segmentation Analysis
Key segments that contributed to the derivation of the biodefense market analysis are by product.
- Based on product, the biodefense market is divided into anthrax, smallpox, botulism, radiation/nuclear, others. The anthrax segment held the largest market share in 2023 and is anticipated to register the highest CAGR during the forecast period.
Biodefense Market Share Analysis by Geography
The geographic scope of the biodefense market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the biodefense market. Biological threats occurring to humans, animals, and environment are among the most serious issues faced by the US and its national community. As the biological threat continues to increase, the US is focused on strengthening its capabilities and considering preparation for biothreats and bioterrorism as one of the critical aspects of national security. A significant focus on national security, a well-established healthcare system, and robust research and development capabilities favor the market’s growth in the region. Due to strong and proactive government activities, partnerships with industry players, and a high degree of preparedness against bioterrorism threats, the region has seen significant investments in biodefense technology, including therapeutics, vaccines, and detection systems.
Biodefense strategies undertaken by organizations, such as BARDA, NIAID, CDC, ASPR, and the FDA, are contributing to the region’s growth. Significant funding by the US military and civilian agencies for biodefense is also one of the key factors responsible for the region's highest revenue share.
Asia Pacific is anticipated to grow with the highest CAGR in the coming years. Due to expanding R&D investments, the significance of biodefense, and the growing threat of dangerous biological materials that cause emergencies are supporting the market growth in the region. The region's high susceptibility to infectious diseases and large population have also increased demand for biodefense products and technologies, coupled with the presence of sophisticated healthcare infrastructure.
Biodefense Market Report Scope
Biodefense Market News and Recent Developments
The biodefense market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for biodefense and strategies:
- In February 2022, Appili Therapeutics Inc. announced funding of over US$ 10 million from the US Department of Defense, via the Joint Science and Technology Office of the Defense Threat Reduction Agency, to advance the company’s biodefense vaccine candidate, ATI-1701, a potential first-in-class vaccine candidate to prevent infection with Francisella tularensis. The funding is expected to boost the company's presence and increase growth in the biodefense market. (Source: Appili Therapeutics, Press Release, 2022)
- In September 2022, Emergent BioSolutions Inc. completed its definitive agreement with Chimerix, Inc. to acquire Chimerix's exclusive global rights to TEMBEXA (brincidofovir), the first oral antiviral approved by the US Food and Drug Administration (FDA) for the treatment of smallpox in all age groups. (Source: Emergent BioSolutions Inc., News Release, 2022)
- In July 2023, Emergent BioSolutions Inc. received approval from the US FDA for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in individuals 18 to 65 years of age when administered in conjunction with recommended antibacterial drugs. (Source: Emergent BioSolutions Inc., News Release, 2023)
Biodefense Market Report Coverage and Deliverables
The “Biodefense Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
- Bavarian Nordic
- Alnylam Pharmaceuticals, Inc.
- SIGA Technologies
- Emergent BioSolutions Inc.
- Cleveland Bio Labs
- Dynavax Technologies
- Elusys Therapeutics, Inc.
- Soligenix
- Altimmune
- Pluristem
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Biodefense Market
May 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
May 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
May 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Bioreactors Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization), and Geography
May 2024
Poultry Diagnostics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others], Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others), and Geography
May 2024
ELISA Diagnostics Tests Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography
May 2024
Direct-To-Consumer Genetic Testing Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Test Type (Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), Distribution Channel (Online and Offline), and Geography
May 2024
Transient Protein Expression Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For